Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Business
    • Entertainment
    • Lifestyle
    • National
    • Technology
    • Education
    • Health
    • E Magazine
      • Year 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Vaishali Pharma will take over the domestic and international marketing operations of Sankalp Life Care, agreement signed between the two companies – Primex News Network
    Business

    Vaishali Pharma will take over the domestic and international marketing operations of Sankalp Life Care, agreement signed between the two companies – Primex News Network

    By April 20, 2022No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mr. Atul Vasani, Managing Director – Vaishali Pharma Ltd.

    Ahmedabad (Gujarat) [India], April 20: Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma Ltd., a leading manufacturer and exporter of pharma formulations, have come together to form a unique partnership that will help both companies grow faster.

    As per the agreement between the two companies, NSE-listed Vaishali Pharma Ltd. will take over the entire domestic and international marketing of Sankalp Life Care’s portfolio of nutraceutical products.

    “This is a perfect partnership. Sankalp Life Care’s core strength is in manufacturing the best quality nutraceutical products, and Vaishali Pharma has a wide global presence in the Indian and multiple markets and specializes in marketing. The partnership will allow us to leverage Vaishali Pharma’s marketing reach and focus on our expertise. It is a win-win for both companies, and we look forward to growing together and offering the highest-quality nutraceutical products to customers in India and around the world,” said Dimple Goenka, Director, Sankalp Life Care.

    Mrs. Dimple Goenka, Director – Sankalp Life Care

    “This agreement between Vaishali Pharma and Sankalp Life Care is the first-of-its-kind in the Indian Pharma Industry. Vaishali Pharma will handle the complete domestic and international marketing operations of Sankalp Life Care and make Sankalp Life Care’s 100+ innovative products available in more than 40 countries. The unique agreement builds on the strengths of the two companies and will be mutually beneficial,” said Atul Vasani, Managing Director, Vaishali Pharma Ltd.

    Sankalp Life Care is a leading nutraceuticals company and has set up the 5th largest nutraceuticals facility in the country at Bavla, Ahmedabad. A range of tablets, capsules, powders, sachets, gummies, liquid and effervescent tablets, among other products, are made at the zero-discharge facility, which is fully operational now and has been designed as per standards defined by World Health Organisation. It is also designed as per USFDA standards, and the company has already made an application for USFDA approval for the facility.

    Vaishali Pharma, which manufactures and exports pharma formulations in a wide spectrum of dosage forms & therapeutic segments, Active Pharmaceutical Ingredients (APIs), surgical products, nutraceutical, and oncology products, is one of the fastest-growing and most versatile companies in the industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and non-regulated markets across the globe.

    www.vaishalipharma.com

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Government schemes to reach small businesses faster as MoFPI and CASMB explore closer collaboration

    July 13, 2026

    Inside the Society: How India’s Communities Are Rebuilding the Neighbourhood, and the Trust That Came with It

    July 13, 2026

    Adisoft Technologies Q1 FY27 Revenue up 78% YoY to ₹30.61 Crore; Order Book and Pipeline crosses ₹96 Crore

    July 13, 2026

    Comments are closed.

    Recent Post
    • NEET 2026 and the Doctor Dream: How Indian Medical Aspirants Are Exploring Global Pathways to Become Doctors
    • Government schemes to reach small businesses faster as MoFPI and CASMB explore closer collaboration
    • Inside the Society: How India’s Communities Are Rebuilding the Neighbourhood, and the Trust That Came with It
    • Nidarshana Gowani Announces Two Grand Editions of ‘Hema Malini LIVE In Concert’ in Mumbai Nehru Centre and Delhi
    • XLRI and Dale Carnegie India Join Hands to Shape Future-Ready Leaders with World-Class Behavioural Skills
    • Asia’s Golden Icon Awards 2026 Celebrates Excellence; Dr. Sailesh Lachu Hiranandani Applauds Launch of ‘Creating Future Icons’
    • Adhiraj Broghar LLP Marks a Significant Milestone with Bhoomi Pujan Ceremony in Dholera SIR
    • ’70–80% of Medical Issues Don’t Need Hospitalization’ — Ashish Srivastava’s Visionary Day-Care Model

    Type above and press Enter to search. Press Esc to cancel.